Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001999371-25-005478
Filing Date
2025-05-06
Accepted
2025-05-06 09:00:14
Documents
7
Period of Report
2025-06-20

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT centessa_proxy-2025.htm DEF 14A 1833651
2 GRAPHIC centessa_proxy-2025img001.gif GRAPHIC 102431
3 GRAPHIC centessa_proxy-2025img002.gif GRAPHIC 508933
4 GRAPHIC centessa_proxy-2025img003.gif GRAPHIC 88932
5 GRAPHIC centessa_proxy-2025img004.gif GRAPHIC 77229
6 GRAPHIC proxy-1.jpg GRAPHIC 426229
7 GRAPHIC proxy-2.jpg GRAPHIC 359576
  Complete submission text file 0001999371-25-005478.txt   3988571
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40445 | Film No.: 25915570
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)